These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16413241

  • 1. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
    Azizi M, Bissery A, Peyrard S, Guyene TT, Ozoux ML, Floch A, Ménard J.
    Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
    [Abstract] [Full Text] [Related]

  • 2. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.
    Linz W, Schäfer S, Afkham F, Gerl M, Schmidts HL, Rütten H.
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052
    [Abstract] [Full Text] [Related]

  • 3. Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension.
    Quaschning T, Hocher B, Ruhl S, Kraemer-Guth A, Tilgner J, Wanner C, Galle J.
    Kidney Blood Press Res; 2006 Sep; 29(6):351-9. PubMed ID: 17139187
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 8. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH, Cha SH, Lee HJ, Lee SW, Park GH, Lee SW, Kim MJ.
    Nephrol Dial Transplant; 2006 Mar 15; 21(3):683-9. PubMed ID: 16330466
    [Abstract] [Full Text] [Related]

  • 9. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P, Buclin T, Nussberger J, Décosterd LA, La Roche SD, Brunner-Ferber F, Brunner HR, Biollaz J.
    J Hypertens; 1999 Mar 15; 17(3):427-37. PubMed ID: 10100082
    [Abstract] [Full Text] [Related]

  • 10. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov 15; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM.
    Clin Sci (Lond); 2012 Dec 15; 123(11):649-58. PubMed ID: 22715807
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D, Grima M, Welsch M, Barthelmebs M, Vasmant D, Imbs J.
    Fundam Clin Pharmacol; 1996 Dec 15; 10(5):474-83. PubMed ID: 8902551
    [Abstract] [Full Text] [Related]

  • 16. Dose-effect relationship of perindopril 10, 14 and 20mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteers.
    Monge M, Paquet V, Bergerot D, Zhygalina V, Blanchard A.
    Int J Cardiol; 2016 Nov 01; 222():648-653. PubMed ID: 27517656
    [Abstract] [Full Text] [Related]

  • 17. Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men.
    Regamey F, Maillard M, Nussberger J, Brunner HR, Burnier M.
    Hypertension; 2002 Sep 01; 40(3):266-72. PubMed ID: 12215465
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers.
    Bani M, Colantoni A, Guillaume M, Macchi F, Moroni G, Persiani S.
    Br J Clin Pharmacol; 2000 Oct 01; 50(4):338-49. PubMed ID: 11012557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M, Ménard J, Bissery A, Guyenne TT, Bura-Rivière A, Vaidyanathan S, Camisasca RP.
    J Am Soc Nephrol; 2004 Dec 01; 15(12):3126-33. PubMed ID: 15579516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.